These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 11073947)
1. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. Di Lisa F; Menabò R; Canton M; Barile M; Bernardi P J Biol Chem; 2001 Jan; 276(4):2571-5. PubMed ID: 11073947 [TBL] [Abstract][Full Text] [Related]
2. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Ruiz-Meana M; Garcia-Dorado D; Miró-Casas E; Abellán A; Soler-Soler J Cardiovasc Res; 2006 Sep; 71(4):715-24. PubMed ID: 16860295 [TBL] [Abstract][Full Text] [Related]
4. Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. Khaliulin I; Clarke SJ; Lin H; Parker J; Suleiman MS; Halestrap AP J Physiol; 2007 Jun; 581(Pt 3):1147-61. PubMed ID: 17395631 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury. Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429 [TBL] [Abstract][Full Text] [Related]
7. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha. Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145 [TBL] [Abstract][Full Text] [Related]
8. [Effect of inductors and inhibitors of the mitochondrial permeability transition pore on its opening and release of unidentified mitochondrial factor]. Sahach VF; Vavilova HL; Strutyns'ka NA; Akopova OV Fiziol Zh (1994); 2003; 49(1):3-12. PubMed ID: 12669514 [TBL] [Abstract][Full Text] [Related]
9. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Petrosillo G; Di Venosa N; Moro N; Colantuono G; Paradies V; Tiravanti E; Federici A; Ruggiero FM; Paradies G Free Radic Biol Med; 2011 Feb; 50(3):477-83. PubMed ID: 21130864 [TBL] [Abstract][Full Text] [Related]
10. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution. Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698 [TBL] [Abstract][Full Text] [Related]
11. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185 [TBL] [Abstract][Full Text] [Related]
12. Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Saotome M; Katoh H; Yaguchi Y; Tanaka T; Urushida T; Satoh H; Hayashi H Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1125-32. PubMed ID: 19202002 [TBL] [Abstract][Full Text] [Related]
13. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Javadov S; Choi A; Rajapurohitam V; Zeidan A; Basnakian AG; Karmazyn M Cardiovasc Res; 2008 Jan; 77(2):416-24. PubMed ID: 18006455 [TBL] [Abstract][Full Text] [Related]
14. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Liu YN; Zhou ZM; Chen P Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891 [TBL] [Abstract][Full Text] [Related]
15. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats. Zhang CX; Cheng Y; Liu DZ; Liu M; Cui H; Zhang BL; Mei QB; Zhou SY J Nanobiotechnology; 2019 Jan; 17(1):18. PubMed ID: 30683110 [TBL] [Abstract][Full Text] [Related]
16. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A. Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445 [TBL] [Abstract][Full Text] [Related]
17. Purine release: a protective signaling mechanism of the mitochondrial permeability transition pore in ischemia. Nadtochiy SM; Nauduri D; Shimanskaya TV; Sagach VF; Brookes PS Fiziol Zh (1994); 2008; 54(6):5-14. PubMed ID: 19227234 [TBL] [Abstract][Full Text] [Related]